These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24699507)

  • 21. Clinical performance targets and quality of life in hemodialysis patients.
    Mazairac AH; de Wit GA; Grooteman MP; Penne EL; van der Weerd NC; den Hoedt CH; Lévesque R; van den Dorpel MA; Nubé MJ; Ter Wee PM; Blankestijn PJ; Bots ML
    Blood Purif; 2012; 33(1-3):73-9. PubMed ID: 22212621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemoglobin variability as a predictor of mortality: What's a practitioner to do?
    Wish JB
    Am J Kidney Dis; 2011 Feb; 57(2):190-3. PubMed ID: 21251539
    [No Abstract]   [Full Text] [Related]  

  • 23. [Measuring quality of life in chronic kidney disease patients: reflections and prospects].
    Yen M; Lin TC; Yang WC
    Hu Li Za Zhi; 2011 Apr; 58(2):5-9. PubMed ID: 21455886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemoglobin variability and mortality: confounding by disease severity.
    Weinhandl ED; Peng Y; Gilbertson DT; Bradbury BD; Collins AJ
    Am J Kidney Dis; 2011 Feb; 57(2):255-65. PubMed ID: 20801571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietic stimulating agents and quality of a patient's life: individualizing anemia treatment.
    Kliger AS; Fishbane S; Finkelstein FO
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):354-7. PubMed ID: 22266571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reflections on 'Survival is not enough--quality of life in CKD'.
    Mallamaci F
    J Nephrol; 2008; 21 Suppl 13():S163-4. PubMed ID: 18446752
    [No Abstract]   [Full Text] [Related]  

  • 27. [Design of a quality of life questionnaire in Spanish for children with chronic kidney disease].
    Aparicio López C; Fernández Escribano A; Garrido Cantanero G; Luque de Pablos A; Izquierdo García E
    Nefrologia; 2010; 30(2):168-76. PubMed ID: 20038971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prioritizing the quality of life of older adults with kidney disease.
    Hall RK
    Nat Rev Nephrol; 2021 Mar; 17(3):149-150. PubMed ID: 33473235
    [No Abstract]   [Full Text] [Related]  

  • 29. Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients.
    Kwan JT; Pratt RD;
    Curr Med Res Opin; 2007 Feb; 23(2):307-11. PubMed ID: 17288685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing a self-administered CKD symptom assessment instrument.
    Agarwal R
    Nephrol Dial Transplant; 2010 Jan; 25(1):160-6. PubMed ID: 19717826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of anemia in chronic kidney disease: understandings in 2006.
    Levin A
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):267-71. PubMed ID: 17420672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
    Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: con.
    Himmelfarb J; Szczech LA
    J Am Soc Nephrol; 2009 Jul; 20(7):1441-3. PubMed ID: 19579287
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of Kidney Disease Quality of Life (KDQOL-36) with mortality and hospitalization in older adults receiving hemodialysis.
    Hall RK; Luciano A; Pieper C; Colón-Emeric CS
    BMC Nephrol; 2018 Jan; 19(1):11. PubMed ID: 29334904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Psychological characteristics and quality of life of patients with chronic kidney diseases].
    Petrova NN; Savvina NN; Vasil'eva IA
    Ter Arkh; 2003; 75(6):31-7. PubMed ID: 12920956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point?
    Covic A; Seica A; Gusbeth-Tatomir P; Goldsmith D
    J Nephrol; 2008; 21(4):478-84. PubMed ID: 18651536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health utilities associated with hemoglobin levels and blood loss in postmenopausal women: the Women's Health Initiative.
    Harrow BS; Eaton CB; Roberts MB; Assaf AR; Luo X; Chen Z
    Value Health; 2011 Jun; 14(4):555-63. PubMed ID: 21669380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mental disorders and quality of life in pediatric patients with chronic kidney disease.
    Marciano RC; Soares CM; Diniz JS; Lima EM; Silva JM; Canhestro MR; Oliveira AG; Melo CD; Dias CS; Correa H; Oliveira EA
    J Bras Nefrol; 2010; 32(3):316-22. PubMed ID: 21103696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of subscales from the symptoms/problems and effects of kidney disease scales of the kidney disease quality of life instrument.
    Rao S; Carter WB; Mapes DL; Kallich JD; Kamberg CJ; Spritzer KL; Hays RD
    Clin Ther; 2000 Sep; 22(9):1099-111. PubMed ID: 11048907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.